ADAG
Adagene, Inc.
NASDAQ · Healthcare · Biotechnology · CN
$3.31
−1.78%Margins
Gross margin
94.2%
EBITDA margin
-234.5%
EBIT margin
-240.3%
Net margin
-220.7%
FCF margin
-209.0%
-19.4%
Return on equity
-15.4%
Return on assets
-20.0%
Return on invested capital
0.09x
Asset turnover
-$19.3M
Cash from operations
$1.91
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026